About Indivior

Sponsor retains sole responsibility for content.

Indivior is a global specialty pharmaceutical company, focused exclusively on addiction medicine. Indivior has a 20-year legacy of health policy and patient advocacy and partnered with the National Institute on Drug Abuse to develop the first buprenorphine-based treatment for opioid use disorder (OUD) in the United States. For more than a decade, Indivior has worked together with stakeholders to...

Indivior is a global specialty pharmaceutical company, focused exclusively on addiction medicine. Indivior has a 20-year legacy of health policy and patient advocacy and partnered with the National Institute on Drug Abuse to develop the first buprenorphine-based treatment for opioid use disorder (OUD) in the United States. For more than a decade, Indivior has worked together with stakeholders to support patients. Today, Indivior has a global portfolio of OUD treatments and a pipeline of investigational medicines to address unmet patient needs in OUD and other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder (AUD) and schizophrenia. Putting patients first defines Indivior’s R&D mission: optimizing drug delivery, decreasing dosing frequency, increasing treatment adherence and retention, decreasing diversion and misuse, improving management of overdose, and treating the comorbidities of addiction. At Indivior, our ultimate goal is to transform addiction from a human crisis to a recognized and treated disease. Addiction can be treated. Innovating together, we can take on the opioid crisis and drug addiction and reclaim lives.

Contact Indivior

Phone Number
+1-804-594-4456

More About Indivior

Therapeutic Areas
  • Central Nervous System
Technologies
  • Drug delivery
Company Type
  • Pharmaceutical
State of Ownership
  • Private
Sponsorship Group
  • Networker